Gamze Ugurluer, Famke L Schneiders, Stefanie Corradini, Luca Boldrini, Rupesh Kotecha, Patrick Kelly, Lorraine Portelance, Philip Camilleri, Merav A Ben-David, Spencer Poiset, Sebastian N Marschner, Giulia Panza, Tugce Kutuk, Miguel A Palacios, Alessandra Castelluccia, Teuta Zoto Mustafayev, Banu Atalar, Suresh Senan, Enis Ozyar
PURPOSE: Stereotactic body radiotherapy (SBRT) is an effective treatment for adrenal gland metastases, but it is technically challenging and there are concerns about toxicity. We performed a multi-institutional pooled retrospective analysis to study clinical outcomes and toxicities after MR-guided SBRT (MRgSBRT) using for adrenal gland metastases. METHODS AND MATERIALS: Clinical and dosimetric data of patients treated with MRgSBRT on a 0.35 T MR-Linac at 11 institutions between 2016 and 2022 were analyzed...
May 2024: Clinical and Translational Radiation Oncology